114 related articles for article (PubMed ID: 29747088)
1. Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.
Carnevale R; Nocella C; Pignatelli P; Bartimoccia S; Stefanini L; Basili S; Novo M; D'Amico A; Cammisotto V; Pastori D; Violi F
Atherosclerosis; 2018 Jul; 274():29-34. PubMed ID: 29747088
[TBL] [Abstract][Full Text] [Related]
2. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
3. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
4. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
Pignatelli P; Pastori D; Carnevale R; Farcomeni A; Cangemi R; Nocella C; Bartimoccia S; Vicario T; Saliola M; Lip GY; Violi F
Thromb Haemost; 2015 Mar; 113(3):617-24. PubMed ID: 25392853
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
Tancin Lambert A; Kong XY; Ratajczak-Tretel B; Atar D; Russell D; Skjelland M; Bjerkeli V; Skagen K; Coq M; Schordan E; Firat H; Halvorsen B; Aamodt AH
Cerebrovasc Dis Extra; 2020; 10(1):11-20. PubMed ID: 32028277
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
7. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
8. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
9. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation.
Tokunaga K; Yamagami H; Koga M; Todo K; Kimura K; Itabashi R; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Kario K; Yagita Y; Kitazono T; Kinoshita N; Takasugi J; Okata T; Yoshimura S; Sato S; Arihiro S; Toyoda K;
Cerebrovasc Dis; 2018; 45(3-4):170-179. PubMed ID: 29597211
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
[TBL] [Abstract][Full Text] [Related]
11. Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.
Becattini C; Dentali F; Camporese G; Sembolini A; Rancan E; Tonello C; Manina G; Padayattil S; Agnelli G
Atherosclerosis; 2018 Apr; 271():177-181. PubMed ID: 29524860
[TBL] [Abstract][Full Text] [Related]
12. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
[TBL] [Abstract][Full Text] [Related]
13. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.
Perri L; Pastori D; Pignatelli P; Violi F; Loffredo L
Int J Cardiol; 2015 Jan; 179():139-43. PubMed ID: 25464433
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
15. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
[TBL] [Abstract][Full Text] [Related]
16. Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation.
Pastori D; Farcomeni A; Saliola M; Del Sole F; Pignatelli P; Violi F; Lip GYH;
Eur J Intern Med; 2018 Aug; 54():34-39. PubMed ID: 29655807
[TBL] [Abstract][Full Text] [Related]
17. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
[TBL] [Abstract][Full Text] [Related]
18. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
Potpara TS; Stankovic GR; Beleslin BD; Polovina MM; Marinkovic JM; Ostojic MC; Lip GYH
Chest; 2012 Feb; 141(2):339-347. PubMed ID: 21622553
[TBL] [Abstract][Full Text] [Related]
19. Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease.
Reichert S; Triebert U; Santos AN; Hofmann B; Schaller HG; Schlitt A; Schulz S
Atherosclerosis; 2017 Nov; 266():234-239. PubMed ID: 28864204
[TBL] [Abstract][Full Text] [Related]
20. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]